Immunocore Holdings plc
IMCR
$33.98
-$0.50-1.44%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 20.95% | 23.75% | 28.95% | 28.10% | 26.78% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.95% | 23.75% | 28.95% | 28.10% | 26.78% |
| Cost of Revenue | 23.10% | 32.79% | 33.49% | 4,106.79% | 1,355.01% |
| Gross Profit | 18.63% | 14.58% | 23.64% | -41.45% | -42.21% |
| SG&A Expenses | 2.06% | 4.07% | 6.18% | 6.58% | 3.88% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -9.29% | -9.29% | -9.29% | -2,112.37% | -2,112.37% |
| Total Operating Expenses | 12.76% | 17.74% | 17.38% | 11.33% | 8.16% |
| Operating Income | 89.96% | 50.13% | 51.11% | 60.75% | 61.94% |
| Income Before Tax | 87.77% | 47.69% | 63.92% | 47.68% | 62.22% |
| Income Tax Expenses | 857.26% | 1,465.97% | 987.24% | 116.36% | 52.25% |
| Earnings from Continuing Operations | 11.02% | -27.46% | 30.48% | 37.88% | 62.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.02% | -27.46% | 30.48% | 37.88% | 62.99% |
| EBIT | 89.96% | 50.13% | 51.11% | 60.75% | 61.94% |
| EBITDA | 103.08% | 55.40% | 53.62% | 63.84% | 65.16% |
| EPS Basic | 11.21% | -26.83% | 31.19% | 38.37% | 63.26% |
| Normalized Basic EPS | 73.63% | 24.84% | 40.91% | 36.48% | 51.93% |
| EPS Diluted | 9.91% | -26.69% | 31.47% | 38.68% | 62.84% |
| Normalized Diluted EPS | 72.31% | 23.98% | 41.24% | 36.81% | 51.41% |
| Average Basic Shares Outstanding | 1.07% | 0.87% | 0.65% | 0.69% | 0.95% |
| Average Diluted Shares Outstanding | -0.16% | -0.35% | 0.18% | 0.23% | 0.74% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |